http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2214648-A2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7b6c089c2c8d445884aa559b243db1c0
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-146
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2095
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16
filingDate 2008-10-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_99cdbe0bf67748e3a57e7982ee267156
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f589bafe2af435e273b6a73b051dabeb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a38c67feefdd64be2ffc16aa6e992837
publicationDate 2010-08-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-2214648-A2
titleOfInvention Stabilized statins
abstract Disclosed is a pharmaceutical composition comprising a mixture of a basic granulate made of at least one pharmaceutically acceptable adjuvant, atorvastatin or rosuvastatin or pharmaceutically acceptable salts thereof, and other optional pharmaceutically acceptable adjuvants. Said pharmaceutical composition is characterized, inter alia, in that the active substance contained therein is stabilized in an amorphous or metastable crystalline form.
priorityDate 2007-10-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID98535
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6235
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226841693
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID129806
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226426463
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60823
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395936
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60822
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128032796
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87172279
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395935
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8567
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399539
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21924385
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2146
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID123915
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9851656
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129742546
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID91358487
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID248252387
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID656606
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394721
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6439133
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID446157
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID247480716
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID104938
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406928
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394949
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399756
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226415785
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID227155340
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136137898
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226408288
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128793030
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID443953
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226443623
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID232

Total number of triples: 53.